General Information of Drug Combination (ID: DCPATV2)

Drug Combination Name
Clascoterone AS-1949490
Indication
Disease Entry Status REF
Chronic myelogenous leukemia Investigative [1]
Component Drugs Clascoterone   DMPGR1E AS-1949490   DMZ1OO0
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL
High-throughput Screening Result Testing Cell Line: KBM-7
Zero Interaction Potency (ZIP) Score: 9.29
Bliss Independence Score: 9.29
Loewe Additivity Score: 21.82
LHighest Single Agent (HSA) Score: 21.82

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)
Indication(s) of Clascoterone
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [2]
Clascoterone Interacts with 1 DTT Molecule(s)
DTT Name DTT ID UniProt ID Mode of Action REF
Androgen receptor (AR) TTS64P2 ANDR_HUMAN Antagonist [2]
------------------------------------------------------------------------------------
Indication(s) of AS-1949490
Disease Entry ICD 11 Status REF
Non-insulin dependent diabetes 5A11 Investigative [3]

References

1 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
3 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.